HIKAL
Small Cap BSE: 524735 NSE: HIKAL
₹344.95
9.35 (2.79%)
As on 26 November, 2022 | 14:36

Hikal Share Price

Hikal Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in HIKAL

Start SIP

Hikal Share Returns

  • Over 1 Month 5.34%
  • Over 3 Month 3.57%
  • Over 6 Month -8.56%
  • Over 1 Year -35.59%

Hikal Key Statistics

P/E Ratio 51.9
PEG Ratio -0.9
Market Cap Cr 4,253
Price to Book Ratio 4
EPS 13
Dividend 0.5
Relative Strength Index 57.37
Money Flow Index 68.4
MACD Signal 0.84
Average True Range 10.72

Hikal Investment Rating

  • Master Rating:
  • Hikal has an operating revenue of Rs. 1,954.42 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 11% is healthy, ROE of 15% is good. The company has a reasonable debt to equity of 27%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around 2% and 1% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 9% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 61 which is a FAIR score but needs to improve its earnings, a RS Rating of 26 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 129 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Hikal Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 557371501515469455532
Operating Expenses Qtr Cr 489356441422378361423
Operating Profit Qtr Cr 702361939196109
Depreciation Qtr Cr 27272425242322
Interest Qtr Cr 1111878810
Tax Qtr Cr 8-3816161830
Net Profit Qtr Cr 25-92145445151

Hikal Technicals

EMA & SMA

Current Price
344.95
9.35 (2.79%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 335.9
  • 50 Day
  • 331.59
  • 100 Day
  • 330.44
  • 200 Day
  • 339.06
  • 20 Day
  • 336.66
  • 50 Day
  • 336.53
  • 100 Day
  • 310.27
  • 200 Day
  • 338.65

Hikal Resistance and Support

PIVOT
₹337.85
Resistance
First Resistance 340.7
Second Resistance 345.8
Third Resistance 348.65
RSI 57.37
MFI 68.41
MACD Single Line 0.84
MACD 1.26
Support
First Resistance 332.75
Second Resistance 329.9
Third Resistance 324.8

Hikal Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 232,142 9,494,608 40.9
Week 135,208 6,365,611 47.08
1 Month 213,807 8,353,445 39.07
6 Month 633,530 22,293,910 35.19

Hikal Result Highlights

Hikal Synopsis

NSE-Medical-Diversified

Hikal Ltd. is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1720.44 Cr. and Equity Capital is Rs. 24.66 Cr. for the Year ended 31/03/2021. Hikal Ltd. is a Public Limited Listed company incorporated on 08/07/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1988PTC048028 and registration number is 048028.
Market Cap 4,253
Sales 1,954
Shares in Float 3.82
No of funds 64
Yield 0.46
Book Value 3.98
U/D Vol ratio 0.9
LTDebt / Equity 27
Alpha -0.15
Beta 1.18

Hikal

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 68.77%68.77%68.77%
Mutual Funds 1.1%0.77%0.76%
Insurance Companies 0.12%0.12%0.12%
Foreign Portfolio Investors 4.27%3.91%6.92%
Individual Investors 19.2%18.54%18.06%
Others 6.54%7.89%5.37%

Hikal Management

Name Designation
Mr. Jai Hiremath Executive Chairman
Mr. Sameer Hiremath Managing Director
Ms. Sugandha Hiremath Director
Mrs. Shivani Bhasin Sachdeva Director
Mr. Ranjit Shahani Director
Mr. Kannan Unni Director
Mr. Amit Kalyani Director
Mr. Baba Kalyani Director
Mr. Prakash Mehta Director
Mr. Shrikrishna Adivarekar Director

Hikal Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Hikal Corporate Action

Date Purpose Remarks
2022-11-09 Quarterly Results
2022-08-10 Quarterly Results
2022-05-28 Audited Results & Final Dividend
2022-02-14 Quarterly Results & Interim Dividend
2021-10-26 Quarterly Results
Date Purpose Remarks
2022-09-15 FINAL Rs.0.40 per share(20%)Final Dividend
2022-02-24 INTERIM Rs.1.20 per share(60%)Interim Dividend
2021-08-26 FINAL Rs.1.00 per share(50%)Final Dividend
2021-02-16 INTERIM Rs.1.00 per share(50%)Interim Dividend

Hikal MF Shareholding

Name Amount(cr)
Tata Small Cap Fund Regular Growth 2664
Motilal Oswal Nifty 500 Fund Regular Growth 368
Nippon India Nifty Smallcap 250 Index Fund Reg Gr 367
Motilal Oswal Nifty Smallcap 250 Index Fund Regular Growth 309
SBI Nifty Smallcap 250 Index Fund Regular Growth 103

Hikal FAQs

What is Share Price of Hikal ?

Hikal share price is ₹344 As on 26 November, 2022 | 14:22

What is the Market Cap of Hikal ?

The Market Cap of Hikal is ₹4253.3 Cr As on 26 November, 2022 | 14:22

What is the P/E ratio of Hikal ?

The P/E ratio of Hikal is 51.9 As on 26 November, 2022 | 14:22

What is the PB ratio of Hikal ?

The PB ratio of Hikal is 4 As on 26 November, 2022 | 14:22

Q2FY23